| Metric | Q3 2022 | Q2 2022 | Q3 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $203M | — | — | — | — |
| Op. Income | $31M | — | — | — | — |
| Gross Margin | 35.6% | — | — | — | — |
| Net Margin | 15.6% | — | — | — | — |
| EPS (Diluted) | $1.11 | — | — | — | — |
| Free Cash Flow | $18M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $203M |
| Cost of Revenue | $131M |
| GROSS PROFIT | $72M |
| R&D Expenses | $17M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $25M |
| Other Expenses | $0 |
| Operating Expenses | $41M |
| Cost & Expenses | $172M |
| OPERATING INCOME | $31M |
| Interest Income | $0 |
| Interest Expense | $308.0K |
| Other Income/Expenses | $3M |
| INCOME BEFORE TAX | $35M |
| Income Tax Expense | $3M |
| Net Income from Continuing Ops | $32M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $32M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $32M |
| D&A | $9M |
| EBIT | $31M |
| EBITDA | $40M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $203M |
| Cost of Revenue | $131M |
| GROSS PROFIT | $72M |
| R&D Expenses | $17M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $25M |
| Other Expenses | $0 |
| Operating Expenses | $41M |
| Cost & Expenses | $172M |
| OPERATING INCOME | $31M |
| Interest Income | $0 |
| Interest Expense | $308.0K |
| Other Income/Expenses | $3M |
| INCOME BEFORE TAX | $35M |
| Income Tax Expense | $3M |
| Net Income from Continuing Ops | $32M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $32M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $32M |
| D&A | $9M |
| EBIT | $31M |
| EBITDA | $40M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $32M |
| Depreciation & Amortization | $9M |
| Stock-Based Compensation | $8M |
| Deferred Income Tax | $2M |
| Other Non-Cash Items | -$3M |
| Change in Working Capital | $15M |
| OPERATING CASH FLOW | $62M |
| Capital Expenditure | -$43M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$43M |
| Net Debt Issuance | $43M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$7M |
| NET CASH FROM FINANCING | $36M |
| FREE CASH FLOW | $18M |
| Net Change in Cash | $54M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $323M |
| Short-Term Investments | $0 |
| Net Receivables | $40M |
| Inventory | $144M |
| Other Current Assets | $236.0K |
| TOTAL CURRENT ASSETS | $518M |
| PP&E (Net) | $290M |
| Goodwill | $269.0K |
| Intangible Assets | $11M |
| Long-Term Investments | $380M |
| Tax Assets | $436.0K |
| Other Non-Current Assets | $10M |
| TOTAL NON-CURRENT ASSETS | $691M |
| TOTAL ASSETS | $1.2B |
| Account Payables | $70M |
| Short-Term Debt | $11M |
| Deferred Revenue | $35M |
| Other Current Liabilities | $26M |
| TOTAL CURRENT LIABILITIES | $199M |
| Long-Term Debt | $54M |
| Deferred Revenue NC | $72M |
| Deferred Tax Liabilities | $29M |
| Other Non-Current Liabilities | $1M |
| TOTAL NON-CURRENT LIABILITIES | $183M |
| TOTAL LIABILITIES | $382M |
| Common Stock | $67.0K |
| Additional Paid-In Capital | $277M |
| Retained Earnings | $615M |
| Treasury Stock | -$66M |
| Accum. Other Comp. Income | $1M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $827M |
| Minority Interest | $0 |
| TOTAL EQUITY | $827M |
| TOTAL LIABILITIES & EQUITY | $1.2B |
| Total Debt | $96M |
| Net Debt | -$227M |
